Navigation Links
Study explores the role of uncertainty in infectious disease modelling
Date:10/21/2013

Research by scientists at the University of Liverpool has found that greater consideration of the limitations and uncertainties present in every infectious disease model would improve its effectiveness/usefulness and value.

Infectious disease dynamical modelling plays a central role in planning for outbreaks of human and livestock diseases, in projecting how they might progress and guiding and informing policy responses.

Modelling is commissioned by governments or may be developed independently by researchers. It has been used to inform policy decisions for human and animal diseases such as SARS, H1N1 swine influenza, foot-and-mouth disease and is being used to inform action in the campaign to control bovine TB.

In a study published in PLOS One, researchers analysed scientific papers, interviews, policies, reports and outcomes of previous infectious diseases outbreaks in the UK to ascertain the role uncertainties played in previous models and how these were understood by both the designers of the model and the users of the model.

They found that many models used to respond to epidemics provided only cursory reference to the uncertainties of the information and data or the parameters used. Whilst the models were uncertain many still informed action.

Dr Rob Christley, from the University's Institute of Infection and Global Health, said: "It is accepted that models will never be able to predict 100% the size, shape or form of an outbreak and it is recognised that a level of uncertainty always exists in modelling. However, modellers often fear detailed discussion of this uncertainty will undermine the model in the eyes of policy makers.

"This study found that the uncertainties and limitations of a model are sometimes hidden and sometimes revealed, and that which occurs is context dependent.

"Whilst it isn't possible to calculate the level of uncertainty, a better understanding and communication of the model's limitations is needed and could lead to better policy."

A model is produced by individuals who have to decide what is important and need to bring together data and information which could include population data, age of population, proximity, type of disease. Uncertainty can occur at all stages of the process from weaknesses in the quality and type of data used, assumptions made about the infectious agent itself, and about the world in which the disease is circulating, all the way through to the technical aspects of the model.


'/>"/>

Contact: Sarah Stamper
sarah.stamper@liv.ac.uk
01-517-943-044
University of Liverpool
Source:Eurekalert

Related biology news :

1. Clean living is a luxury wild animals cant afford, study suggests
2. Study puts freshwater biodiversity on the map for planners and policymakers
3. What makes us left or right handed? New study rules out strong genetic factors
4. Study: Acidity can change cell membrane properties
5. Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication
6. $1.5 million NCI Grant to aid Huntsman Cancer Institute researcher study melanoma, sun damage link
7. Study finds steroids may persist longer in the environment than expected
8. New study offers hope for halting incurable citrus disease
9. Global study reveals new hotspots of fish biodiversity
10. Family Resiliency Center helps study how food-bank clients afford basic non-food items
11. New CU-Boulder-led study finds microbial clock may help determine time of death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... 01, 2016 , ... ACEA Biosciences, Inc. announced today that it will be ... at the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December ... clinical trials for AC0010 in patients with advanced non-small cell lung cancer harboring the ...
(Date:12/2/2016)... ... 2016 , ... DrugDev believes the only way to achieve real ... All three tenets were on display at the 2nd Annual DrugDev User Summit (hosted ... CRO and site organizations to discuss innovation and the future of clinical research. ...
(Date:12/2/2016)... PUNE, India , December 2, 2016 ... Billion by 2021, growing at a CAGR of 7.3% during the ... segment while hospitals and diagnostic laboratories segment accounted for the largest ... ... Complete report on global immunohistochemistry (IHC) market spread across 225 ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
Breaking Biology Technology: